Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Latest on REIT: Annaly Capital Management, Inc. (NLY)’s Dividend, Chimera Investment Corporation (CIM)’s Extension, CYS Investments Inc (CYS)’s Price Target

Editor’s Note: Annaly Capital Management, Inc. (NYSE:NLY), Chimera Investment Corporation (NYSE:CIM), CYS Investments Inc (NYSE:CYS), AG Mortgage Investment Trust Inc (NYSE:MITT)

Interesting October Stock Options for NLY (Forbes)
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Annaly Capital Management, Inc. (NYSE:NLY). So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for NLY. The put contract our YieldBoost algorithm identified as particularly interesting, is at the $11 strike, which has a bid at the time of this writing of 28 cents. Collecting that bid as the premium represents a 2.5% return against the $11 commitment, or a 23.2% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Annaly Capital Management, Inc. (NYSE:NLY)

Chimera Investment Corporation (NYSE:CIM) – NYSE Listing Extension and the Way Forward (FinancialsTrend)
A real estate investment trust (REIT), Chimera Investment Corporation (NYSE:CIM)’s key investments include agency and non-agency RMBS, residential mortgage loans, commercial mortgage loans, commercial mortgage backed securities (CMBS) and consumer and non-consumer asset backed securities (ABS). Recently CIM has received an extension, provided the company files its FY12 Annual Report with the Securities and Exchange Commission on Form 10-K until January 31, 2014, for continued listing and trading of its stock on the New York Stock Exchange (NYSE). Though during the period of extension trading of Chimera Investment Corporation (NYSE:CIM)’s shares will remain uninterrupted, the extension is subject to ongoing review by NYSE.

CYS Investments Price Target Cut to $10.00 by Analysts at Keefe, Bruyette & Woods (CYUS) (WKRB News)
Equities research analysts at Keefe, Bruyette & Woods reduced their price objective on shares of CYS Investments Inc (NYSE:CYS) from $11.00 to $10.00 in a research note issued to investors on Tuesday, Analyst Ratings reports. The firm currently has an “outperform” rating on the stock. Several other analysts have also recently commented on the stock. Analysts at Nomura cut their price target on shares of CYS Investments from $13.00 to $8.00 in a research note to investors on Friday, August 2nd. Separately, analysts at Wunderlich cut their price target on shares of CYS Investments Inc (NYSE:CYS) from $12.00 to $9.00 in a research note to investors on Tuesday, July 23rd.

AG Mortgage Cuts Dividend by 25% (DailyFinance)
Real estate investment trust AG Mortgage Investment Trust Inc (NYSE:MITT) has announced plans to pay a dividend of $0.60 this quarter. The new payout is a 25% drop from last quarter’s payout of $0.80 per share, which the company had paid since January 2013. AG Mortgage’s latest quarterly dividend will be payable on Oct. 28 to shareholders of record as of Sept. 19. The company has paid a dividend since September 2011.

Annaly Capital Management, Inc. (NYSE:NLY) able to manage volatility? (FinancialsTrend)
Annaly Capital Management, Inc. (NYSE:NLY) is definitely a tempting stock. Its dividend is above 13%. The company’s chart looks like it is bottoming out. The U.S economic data has been quite tepid and this has led many people to presume that whatever rate-spike that had to take place due to the Fed taper speculation, is done with. This fact has not been lost on investors. At a cursory glance, to any yield seeker or bargain hunter this will definitely seem like a good bargain.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!